Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi

Malawi experienced prolonged use of sulfadoxine/pyrimethamine (SP) as the front-line anti-malarial drug, with early replacement of chloroquine and delayed introduction of artemisinin-based combination therapy. Extended use of SP, and its continued application in pregnancy is impacting the genomic va...

Bibliográfalaš dieđut
Váldodahkkit:	Ravenhall, M, Benavente, E, Mipando, M, Jensen, A, Sutherland, C, Roper, C, Sepúlveda, N, Kwiatkowski, D, Montgomery, J, Phiri, K, Terlouw, A, Craig, A, Campino, S, Ocholla, H, Clark, T
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	BioMed Central 2016

Geahča maid

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Dahkki: Peto, T, et al.
Almmustuhtton: (1985)

Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
Dahkki: Femmy Tambajong, et al.
Almmustuhtton: (2016-10-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
Dahkki: Basco Leonardo K., et al.
Almmustuhtton: (2002-01-01)

Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia
Dahkki: Warsame M., et al.
Almmustuhtton: (2002-01-01)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
Dahkki: Mary C. Oguike, et al.
Almmustuhtton: (2016-12-01)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
Dahkki: Smithuis, F, et al.
Almmustuhtton: (1997)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
Dahkki: Aleisha R. Brock, et al.
Almmustuhtton: (2017-05-01)

Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Dahkki: Barnes, K, et al.
Almmustuhtton: (2008)

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Dahkki: Sulo, J, et al.
Almmustuhtton: (2002)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
Dahkki: Lederman, E, et al.
Almmustuhtton: (2006)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
Dahkki: Floriano Amimo, et al.
Almmustuhtton: (2020-11-01)

Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia
Dahkki: Lyda Osorio, et al.
Almmustuhtton: (2002-12-01)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against <it>Plasmodium falciparum </it>in Central Java, Indonesia
Dahkki: Estiana Lusi, et al.
Almmustuhtton: (2006-11-01)

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan
Dahkki: Adnan Yaqoob, et al.
Almmustuhtton: (2018-12-01)

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru
Dahkki: A. Llanos-Cuentas, et al.

Sulfadoxine-pyrimethamine for the treatment of malaria.
Dahkki: White, N
Almmustuhtton: (1991)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
Dahkki: Jennifer A Flegg, et al.
Almmustuhtton: (2022-08-01)

Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia
Dahkki: Sukmawati Basuki, et al.
Almmustuhtton: (2018-12-01)

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru
Dahkki: Alan J. Magill, et al.
Almmustuhtton: (2004-06-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
Dahkki: Sokhina C.S, et al.
Almmustuhtton: (2001-09-01)

A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos.
Dahkki: Mayxay, M, et al.
Almmustuhtton: (2003)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
Dahkki: Divya Goel, et al.
Almmustuhtton: (2016-01-01)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
Dahkki: Ratcliff, A, et al.
Almmustuhtton: (2007)

Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
Dahkki: Maguire, J, et al.
Almmustuhtton: (2002)

A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria
Dahkki: Adebanjo J. Adegbola, et al.
Almmustuhtton: (2023-03-01)

Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso
Dahkki: Traore Corneille, et al.
Almmustuhtton: (2004-05-01)

Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
Dahkki: A Sowunmi, et al.
Almmustuhtton: (2005-07-01)

Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana
Dahkki: Lucas N. Amenga-Etego, et al.
Almmustuhtton: (2021-03-01)

Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment
Dahkki: TO Ogungbamigbe, et al.
Almmustuhtton: (2008-02-01)

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin
Dahkki: Sayeh Jafari-Guemouri, et al.
Almmustuhtton: (2018-10-01)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
Dahkki: Sesh A. Sundararaman, et al.
Almmustuhtton: (2022-08-01)

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
Dahkki: Barnes, K, et al.
Almmustuhtton: (2006)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
Dahkki: Thiery Masserey, et al.

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
Dahkki: Ashish Pathak, et al.
Almmustuhtton: (2020-08-01)

Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.
Dahkki: David J Bell, et al.
Almmustuhtton: (2008-02-01)

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
Dahkki: Jean Claude Djontu, et al.
Almmustuhtton: (2024-12-01)

Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012–2022
Dahkki: Ruimin Zhou, et al.
Almmustuhtton: (2024-11-01)

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon
Dahkki: Rosario Martinez-Vega, et al.
Almmustuhtton: (2024-09-01)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
Dahkki: Rachida Moussa Tari, et al.
Almmustuhtton: (2022-01-01)

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
Dahkki: Rachmawati Rachmawati, et al.
Almmustuhtton: (2010-04-01)